Syndax Pharmaceuticals leukemia drug wins first-in-class FDA approval

The latest stories trending on MedCity News.

Editor's Pick

Top Story Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval Approval of Syndax's Revuforj for acute leukemia makes the twice-daily pill the first in a new class of drugs that block a cancer-driving protein called menin. Other companies developing menin inhibitors include Kura Oncology, Biomea Fusion, and Johnson & Johnson subsidiary Janssen. Sponsored Where To Find Savings Due To Rising Healthcare Costs Presented by Personify Health There is no single remedy to fix extreme healthcare cost challenges. Healthcare inflation cuts across multiple factors. So employers need multiple ways to reverse these trends in 2025.  Join us on December 12th and hear specific examples of how your company can find more savings in more places using AI, and how a personalized health platform can deliver savings. Sign up to hear more ways to save for your company! INVEST: Where People and Connections Drive Innovation Network with industry leaders, collaborate with like-minded innovators, and build the relationships that will define the next wave of healthcare transformation. Join MedCity News at INVEST in Chicago, 29-30 April 2025 and be part of a community that's not just talking about change, but making it happen.  For Best Rate Register Now

Featured News

How Emory's New Partnership Seeks to Scale Value-Based Care Across Georgia Emory Healthcare in Atlanta announced a partnership with Guidehealth, value-based care enablement startup. The collaboration is designed to help primary care reach more than 350,000 patients across Georgia. Evvy Introduces Treatments for Common Vaginal Symptoms Evvy has launched a new line of prescription products to relieve vaginal discomfort. The products are available on the company's website, with prices ranging from $35 to $59. Why AI Won't Replace Human Psychotherapists Despite AI's growing ability to simulate empathy and even outperform humans in some areas of emotional awareness, can it truly replace human therapists and take the burden off the mental health care system? Why We Urgently Need More Widely Available Tests for Alzheimer's Disease Early diagnosis through blood tests buys invaluable time – for patients and their families to plan, seek support, make informed decisions about their difficult care journey and, perhaps most importantly, be together.

Resources

SPONSORED 5 Top-Rated Electronic Medical Records Software for SMBs This report can help small and midsize businesses compare the five top-rated Electronic Medical Record (EMR) software solutions, and offers insights into: Verified user reviews about EMR software Key features of EMR software Actionable recommendations for SMBs to choose the right software Download Free Guide Now

MedCity News • PO Box 901 • New York, NY unsubscribe